Search research articles
Contact Us
Filters
Showing results (61-70 of 72) with videos related to
Page
of 8
Sort By:
Journal of Medical Virology
|
September 3, 2022
Native and activated antithrombin inhibits TMPRSS2 activity and SARS-CoV-2 infection
Lukas Wettstein, Patrick Immenschuh, Tatjana Weil, et al.
Cell Reports
|
October 6, 2021
B.1.617.2 enters and fuses lung cells with increased efficiency and evades antibodies induced by infection and vaccination
Prerna Arora, Anzhalika Sidarovich, Nadine Krüger, et al.
Virology
|
September 9, 2025
Host cell entry efficiency and neutralization sensitivity of the SARS-CoV-2 MC.10.1 variant
Lu Zhang, Amy Kempf, Inga Nehlmeier, et al.
International Journal of Molecular Sciences
|
November 26, 2022
The SARS-CoV-2 Delta-Omicron Recombinant Lineage (XD) Exhibits Immune-Escape Properties Similar to the Omicron (BA.1) Variant
Prerna Arora, Lu Zhang, Cheila Rocha, et al.
The Lancet. Infectious Diseases
|
September 18, 2022
Lung cell entry, cell-cell fusion capacity, and neutralisation sensitivity of omicron sublineage BA.2.75
Prerna Arora, Inga Nehlmeier, Amy Kempf, et al.
Vaccines
|
May 25, 2024
Virological Traits of the SARS-CoV-2 BA.2.87.1 Lineage
Lu Zhang, Alexandra Dopfer-Jablonka, Inga Nehlmeier, et al.
Cell Reports
|
July 16, 2021
SARS-CoV-2 variant B.1.617 is resistant to bamlanivimab and evades antibodies induced by infection and vaccination
Markus Hoffmann, Heike Hofmann-Winkler, Nadine Krüger, et al.
Nature Communications
|
June 13, 2023
Omicron subvariant BA.5 efficiently infects lung cells
Markus Hoffmann, Lok-Yin Roy Wong, Prerna Arora, et al.
Plos One
|
May 12, 2017
Non-human primate orthologues of TMPRSS2 cleave and activate the influenza virus hemagglutinin
Pawel Zmora, Paulina Molau-Blazejewska, Stephanie Bertram, et al.
Viruses
|
January 8, 2025
Immune Response to SARS-CoV-2 XBB.1.5 and JN.1 Variants Following XBB.1.5 Booster Vaccination in Liver Transplant Recipients
Philippa von der Schulenburg, Georg M N Behrens, Markus Hoffmann, et al.
Page
of 8
Search research articles
Search
Showing results (61-70 of 72) with videos related to
Sort By:
Page
of 8
Journal of Medical Virology
|
September 3, 2022
Native and activated antithrombin inhibits TMPRSS2 activity and SARS-CoV-2 infection
Lukas Wettstein, Patrick Immenschuh, Tatjana Weil, et al.
Cell Reports
|
October 6, 2021
B.1.617.2 enters and fuses lung cells with increased efficiency and evades antibodies induced by infection and vaccination
Prerna Arora, Anzhalika Sidarovich, Nadine Krüger, et al.
Virology
|
September 9, 2025
Host cell entry efficiency and neutralization sensitivity of the SARS-CoV-2 MC.10.1 variant
Lu Zhang, Amy Kempf, Inga Nehlmeier, et al.
International Journal of Molecular Sciences
|
November 26, 2022
The SARS-CoV-2 Delta-Omicron Recombinant Lineage (XD) Exhibits Immune-Escape Properties Similar to the Omicron (BA.1) Variant
Prerna Arora, Lu Zhang, Cheila Rocha, et al.
The Lancet. Infectious Diseases
|
September 18, 2022
Lung cell entry, cell-cell fusion capacity, and neutralisation sensitivity of omicron sublineage BA.2.75
Prerna Arora, Inga Nehlmeier, Amy Kempf, et al.
Vaccines
|
May 25, 2024
Virological Traits of the SARS-CoV-2 BA.2.87.1 Lineage
Lu Zhang, Alexandra Dopfer-Jablonka, Inga Nehlmeier, et al.
Cell Reports
|
July 16, 2021
SARS-CoV-2 variant B.1.617 is resistant to bamlanivimab and evades antibodies induced by infection and vaccination
Markus Hoffmann, Heike Hofmann-Winkler, Nadine Krüger, et al.
Nature Communications
|
June 13, 2023
Omicron subvariant BA.5 efficiently infects lung cells
Markus Hoffmann, Lok-Yin Roy Wong, Prerna Arora, et al.
Plos One
|
May 12, 2017
Non-human primate orthologues of TMPRSS2 cleave and activate the influenza virus hemagglutinin
Pawel Zmora, Paulina Molau-Blazejewska, Stephanie Bertram, et al.
Viruses
|
January 8, 2025
Immune Response to SARS-CoV-2 XBB.1.5 and JN.1 Variants Following XBB.1.5 Booster Vaccination in Liver Transplant Recipients
Philippa von der Schulenburg, Georg M N Behrens, Markus Hoffmann, et al.
Page
of 8